Salmovir -inaktywowany wirus PMV-1 (szczep La Sota): nie mniej niż 1 j. ELISA;-inaktywowane komórki Salmonella (serotypy: S.typhi. S.parathypi. A, S. parathypi. C, S. typhimorium var. Copenhagen, S. anatum, S. senftenberg): nie mniej niż 1 j. ELISA dla każdego serotypu.(1 j. ELISA - ilość antygenu wystarczająca do uzyskania serokonwersji równej lub wyższej 1,8 u szczepionego gołębia) Emulsja do wstrzykiwań
Salmovir -inaktywowany wirus PMV-1 (szczep La Sota): nie mniej niż 1 j. ELISA;-inaktywowane komórki Salmonella (serotypy: S.typhi. S.parathypi. A, S. parathypi. C, S. typhimorium var. Copenhagen, S. anatum, S. senftenberg): nie mniej niż 1 j. ELISA dla każdego serotypu.(1 j. ELISA - ilość antygenu wystarczająca do uzyskania serokonwersji równej lub wyższej 1,8 u szczepionego gołębia) Emulsja do wstrzykiwań
Authorised
- Newcastle disease virus, strain La Sota, Inactivated
- Salmonella enterica, subsp. enterica serovar Typhi, Inactivated
- Salmonella enterica, subsp. enterica serovar Paratyphi A, Inactivated
- Salmonella enterica, subsp. enterica serovar Paratyphi C, Inactivated
- Salmonella enterica, subsp. enterica, serovar Typhimurium, strain Copenhagen, Inactivated
- Salmonella enterica, subsp. enterica serovar Anatum, Inactivated
- Salmonella enterica, subsp. enterica serovar Senftenberg, Inactivated
Product identification
Medicine name:
Salmovir -inaktywowany wirus PMV-1 (szczep La Sota): nie mniej niż 1 j. ELISA;-inaktywowane komórki Salmonella (serotypy: S.typhi. S.parathypi. A, S. parathypi. C, S. typhimorium var. Copenhagen, S. anatum, S. senftenberg): nie mniej niż 1 j. ELISA dla każdego serotypu.(1 j. ELISA - ilość antygenu wystarczająca do uzyskania serokonwersji równej lub wyższej 1,8 u szczepionego gołębia) Emulsja do wstrzykiwań
Active substance:
- Newcastle disease virus, strain La Sota, Inactivated
- Salmonella enterica, subsp. enterica serovar Typhi, Inactivated
- Salmonella enterica, subsp. enterica serovar Paratyphi A, Inactivated
- Salmonella enterica, subsp. enterica serovar Paratyphi C, Inactivated
- Salmonella enterica, subsp. enterica, serovar Typhimurium, strain Copenhagen, Inactivated
- Salmonella enterica, subsp. enterica serovar Anatum, Inactivated
- Salmonella enterica, subsp. enterica serovar Senftenberg, Inactivated
Target species:
-
Pigeon
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Newcastle disease virus, strain La Sota, Inactivated1.00enzyme-linked immunosorbent assay unit0.20millilitre(s)
-
Salmonella enterica, subsp. enterica serovar Typhi, Inactivated1.00enzyme-linked immunosorbent assay unit0.20millilitre(s)
-
Salmonella enterica, subsp. enterica serovar Paratyphi A, Inactivated1.00enzyme-linked immunosorbent assay unit0.20millilitre(s)
-
Salmonella enterica, subsp. enterica serovar Paratyphi C, Inactivated1.00enzyme-linked immunosorbent assay unit0.20millilitre(s)
-
Salmonella enterica, subsp. enterica, serovar Typhimurium, strain Copenhagen, Inactivated1.00enzyme-linked immunosorbent assay unit0.20millilitre(s)
-
Salmonella enterica, subsp. enterica serovar Anatum, Inactivated1.00enzyme-linked immunosorbent assay unit0.20millilitre(s)
-
Salmonella enterica, subsp. enterica serovar Senftenberg, Inactivated1.00enzyme-linked immunosorbent assay unit0.20millilitre(s)
Pharmaceutical form:
-
Emulsion for injection/infusion
Withdrawal period by route of administration:
-
Subcutaneous use
-
Pigeon
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01EA
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biowet Pulawy Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Biowet Pulawy Sp. z o.o.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 0202
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 11/02/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 11/02/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 11/02/2025
How useful was this page?: